Answers are grounded in this paper and cite their sources.
Supplementary Figure 5 shows that trametinib increases the intracellular accumulation of daunorubicin in KRAS-mutant CRC cells.
No takes yet. Share an insight, caveat, or question.
Ghosh et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: